3861 results for «578»
3861 results
How should aortic stenosis be treated in the modern era and what is the role of the heart team?
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the current status of aortic stenosis treatment around the world, to learn more about the patient and treatment selection by the Heart Team, and to discover how the patient pathway's optimization may facilitate the increasing demand for TAVR.
How to optimise coronary intervention therapy with SAPIEN 3
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn through various challenging cases about the optimal timing for performing coronary intervention for TAVI patients, the coronary access techniques for SAPIEN 3 patients and the differences in coronary access between balloon- and self-expandable devices.
How to optimise PCI in a patient with multivessel disease? LIVE Case
19 Dec 2019 – From GulfPCR-GIM 2019
Watch this case of an 81-year-old female with no prior history of CAD who presented with unstable angina. The patient had recent acute coronary syndrome and baseline angiography shows multivessel disease.
The objectives of this case are:
- Assess your patient as a whole package!
- Lesion preparation is key for...
Antithrombotic therapy for AF in bioprosthetic valve
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the anticoagulant therapy for bioprosthetic valves with AF, the optimal stroke prevention strategy after TAVI and the clinical impact of the current data on leaflet thrombosis.
Valve selection for patients with longer life
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about patients with failed surgical bioprosthesis valves' treatment, valve selection impacts clinical and procedural outcomes, and discover some future trends in treating TAVI patients with longer life expectancy which may revolutionize your practice.
Remaining challenges in TAVI: how to achieve the better lifetime outcomes for AS patients
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the remaining challenges in TAVI, such as providing AS patients with the best possible outcomes over their entire lifetime, improving pacemaker implant rates with self-expandable valves, and more!
Challenging cases on mitral interventions, TAVI and LAA closure
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: systolic anterior motion with mitral regurgitation triggered by TAVI, transcatheter mitral valve repair using MitraClip through atrial septal defect, ACS complicating transcaval TAVI, and more!
Abstracts in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of abstracts submitted during PCR Tokyo Valves 2020, such as: impact of beta blockers on patients undergoing TAVR, predictive factors of no symptomatic improvement after TAVI, and more!
TAVI and others
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about a study comparing the treatment's results of patients with bicuspid (BAV) and tricuspid aortic valve (TAV), in whom TAVI was performed, in terms of device success, early safety and clinical efficacy.
Complication cases
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn through a selection of complications cases how to manage transcatheter aortic valve migration, aorto-right ventricular fistula after TAVI, and sudden haemodynamic collapse during TAVI.
Session for the Co-medicals in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session dedicated to the co-medicals, to discover the nurse's perspective on percutaneous LAA closure, a study on the reduction of scattered radiation exposure in TAVI, and more!
Cases in mitral
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging mitral cases, such as MitraClip therapy for dynamic mitral regurgitation with repetitive heart failure exacerbation, transseptal mitral valve-in-valve implantation to elucidate a degree of concomitant aortic valve stenosis, and more!
Cases in Japanese - PCI, MR & TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: PCI for coronary ischemia after EvolutR implantation, degenerative mitral regurgitation with large gap, bailout of ventricular septal defect after TAVI, and more!
Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and...
Shaping care pathways for severe aortic stenosis patients in a COVID-19 context
Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.
Portico FlexNav - Optimise TAVI outcomes from routine to complex cases
Watch this session if you want to learn how Portico enables you to achieve favorable haemodynamics and patient outcomes, to learn about the new Portico with FlexNav TAVI system and its deliverability and to learn the importance of looking ahead during transcatheter aortic valve implantation and...
Hot lines on Mitral interventions – part 1
25 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on mitral interventions presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: EVOQUE replacement, Tendyne TMVI, CLASP, V-i-V and V-i-R, Tendyne MAC.
Physiology or intracoronary imaging; or both? or none? - part 1
27 Jun 2020 – From PCR e-Course 2020
Watch a series of studies on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SCAAR report, a sub-analysis of the FORZA trial, diagnostic accuracy of IVUS-based FFR.
FFR wires passé? Rethinking the physiological assessment of coronary artery disease
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to identify hemodynamic relevance of intermediate coronary lesions with highest diagnostic accuracy to allow individualized therapy and to learn about the new technology of coronary angiography derived FFR & its clinical potential.
PCR e-Course 2020 Hot line: left atrial appendage closure
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on LAA closure presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: LAA occlusion vs. NOAC, Amulet IDE Roll-in cohort, identification of potential LAAC candidates.
